DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactOrders & Deals

Dr. Lal Path Labs Ltd. — Acquisition (including agreement to acquire)-XBRL

NSE 1 hr ago·24 Jul 2026, 9:50 am

DR. LAL Path Labs

Dr. Lal Path Labs Ltd. has informed stock exchanges that it is moving forward with an acquisition, including a signed agreement to complete the deal. The company has filed the relevant XBRL documents to disclose this corporate action to the public.

This news signals a strategic expansion for the pathology and diagnostics major. For investors, such an acquisition typically indicates the company's intent to grow its market share and enhance its service capabilities. It suggests management confidence in the sector and their ability to execute growth plans.

Investors should watch for the company's future press releases to identify the target entity and the financial terms of the agreement. Understanding the strategic rationale and the potential impact on the company's financials will be key to assessing the long-term value of this move.